TIDUTAMAB

Approval Year

Name

Type

Language

TIDUTAMAB

Official Name

English

XMAB18087

Code

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB18087 .GAMMA.1-CHAIN), (265->231'),(268->234')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN SOMATOSTATIN RECEPTOR 2) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB18087 .GAMMA.1-CH

Systematic Name

English

XMAB-18087

Code

English

IMMUNOGLOBULIN HALF-G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS SSTR2 (SOMATOSTATIN RECEPTOR 2) AND HOMO SAPIENS CD3 EPSILON (CD3E, LEU-4)), MONOCLONAL ANTIBODY, BISPECIFICGAMMA1 HEAVY CHAIN ANTI-SSTR2 (1-451) (VH (HOMO SAPIENS IGHV3-48*03 (90.8%)-(IGHD)

Systematic Name

English

TIDUTAMAB [USAN]

Common Name

English

Tidutamab [WHO-DD]

Common Name

English

ANTI-SSTR2/CD3 MONOCLONAL ANTIBODY XMAB18087

Common Name

English

tidutamab [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C28227